Navigation Links
New molecules discovered that block cancer cells from modifying cell DNA
Date:10/11/2007

Lake Tahoe, CA, October 11, 2007 Researchers have discovered new small molecules that may prevent prostate cancer cells from turning off normal genes in a process that transforms normal cells into cancer cells. This significant discovery in the field of epigenetics has immediate implications in the development of new diagnostic tests and cancer medications. The findings were presented today at the Prostate Cancer Foundations annual Scientific Retreat. Funding for the research was provided by the Prostate Cancer Foundation, as well as from the National Cancer Institute and the Avon Foundation.

Epigenetics refers to changes to genes other than changes to the DNA sequence itself, such as the addition of molecules to the DNA strand. While the development of cancer can arise from defective or mutated genes, it can also arise from these changes that can actually prevent a cell from acting as it should. Cancer cells exploit this process, putting some genes in cold storage or turned off by modifying the cell DNA in a process known as methylation.

Lead researcher William Nelson, M.D., Ph.D., Professor of Oncology and Urology at the Johns Hopkins Kimmel Cancer Center, explained the findings. One of the proteins in the cell that triggers this process is called a methyl-CpG binding protein, or MBD. We have discovered an antagonist of MBD2 that keeps this protein from binding to methylated genes. If the protein cant bind to the gene, then it cant keep the gene turned off and the gene is turned back on able to act in the way it is supposed to.

Nelson noted that the discovery is particularly exciting because of previous research that shows the importance of being able to alter the methylation process in DNA. When mice were developed without the gene that permits this process, they dont develop cancer. When the gene is removed from cancer cells, they turn on genes again in appropriate ways. The small molecules that weve discovered mimic thi
'/>"/>

Contact: Sharon Reis
prostate@gymr.com
202-745-5103
GYMR
Source:Eurekalert

Page: 1 2

Related biology news :

1. DNA Molecules Used To Assemble Nanoparticles
2. Inflammatory molecules released by pollen trigger allergies
3. Duke Chemists Isolating Individual Molecules Of Toxic Protein In Alzheimers, Parkinsons Disease
4. Medical molecules designed to respond to visible light that can penetrate tissue
5. Touching Molecules With Your Bare Hands
6. DNA constraints control structure of attached macromolecules
7. Team Invents Device For Weighing Individual Molecules
8. Scientists discover that three molecules may be developed into new Alzheimers drugs
9. Physical and functional interaction of key cell growth molecules linked to cancer
10. Scientists discover new way to look at how molecules twist and turn on water
11. Scientists learn to predict protein-stabilizing ability of small molecules

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...pings of gravy and dessert at the holiday table ar...ously thought. According to a new research report ... http://www.fasebj.org ), a diet that is high in f...timately cause our bodies to store too much fat. T... as the already difficult task of converting high-...
(Date:11/30/2009)...s available in German . , The DFG has appro...arch Centres as of 1 January 2010. This decision w...in Bonn. The new centres will initially be funded ...ition, 20 percent overhead funding for indirect co...ntres, research topics range from modern prosthese...
(Date:11/30/2009)...- The inaugural Global Conference on Systems & Ent... Washington, DC, focuses on the convergence of com...al importance to society. , The goal of the ...ivity around targeted complex systems, examined by...includes Critical Infrastructure Systems, includin...
Breaking Biology News(10 mins):Happy holidays from the groaning board; Western diets turn on fat genes 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Finesse Solutions Expands Into State of the Art Facility in San Jose CA USA 12606 1Aussie and Kiwi researchers make double MS genetic discovery 8821 1Aussie and Kiwi researchers make double MS genetic discovery 8821 2Symbia net Hotspot for Remote Access 48825 1Symbia net Hotspot for Remote Access 48825 2Symbia net Hotspot for Remote Access 48825 3
...sts from around the world will convene at the Univ... key findings from the most ambitious effort ever ...tants in the Arctic and determine how they contrib...way in the vast, climate-sensitive region. , The ...ARCAT was conducted most intensively during two th...
...ands, May 26, 2009 There are several risk factors...scular dementia. Based on an increasing number of ...deficiency, an article in the current issue of the...lliam B. Grant, PhD of the Sunlight, Nutrition, an...rther investigation of possible direct or indirect...
...sen sharply in developed countries in the wake of ...Europeans live with the condition. Foot problems a...for diabetics, who are at risk of serious complica...lood supply to their feet. Both conditions can lea... they get infected and become gangrenous, can lead...
Other Biology News:Spring agricultural fires have large impact on melting Arctic 2Spring agricultural fires have large impact on melting Arctic 3Is vitamin D deficiency linked to Alzheimer's disease and vascular dementia? 2Protective footwear for diabetics at a high-street price 2Protective footwear for diabetics at a high-street price 3
(Date:12/1/2009)...nc. today announced a collaborative research agree... at evaluating EpiVax’s proprietary Tregitop...mental immune responses to certain drugs. In the c...x Tregitope technology will be evaluated for its e...ics. , (Vocus) December 2...
(Date:12/1/2009).... 1 Aethlon Medical, Inc...it will present at the LD MICRO Conference on Thur...uxe Hotel in Los Angeles. Aethlon Medical,s Chairm...te overview and will provide an update on the comp...Hemopurifier®, a first-in-class artificial ad...
(Date:12/1/2009)...na, Dec. 1 /PRNewswire-Asia-FirstCall/ -- China Sk...he Company") (Nasdaq: CSKI ), a leading,fully int...ucing,over-the-counter drugs in the People,s Repub...pany has engaged Guangdong Mediacy Kind Medical De... its exclusive sales agent for the,Company,s AMI D...
(Date:12/1/2009)...wswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bull...d, biopharmaceutical company developing human vacc...iciency Virus) and other infectious agents, today ...oday is the 21st World AIDS Day and as we remember...HIV/AIDS pandemic, we remain focused and devoted t...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6
... Calif., Oct. 29 Sangamo,BioSciences, Inc. (Nasda...cial results and accomplishments., For the third ... a,consolidated net loss of $6.3 million, or $0.15..., or $0.11 per share, for the same period in 2007....ash equivalents and,investments of $59.5 million. ...
...Mass., Oct. 29 Aware, Inc. (Nasdaq:,AWRE), a lead...s software,announced today that its Board of Direc...inally authorized on August 28, 2007 to repurchase...o $5 million worth of shares of,the Company,s comm...cember,31, 2009 at prevailing market prices. The B...
...lion Net Revenues, $0.10 Net Income Per Share, SA...ies, Inc. (Nasdaq: VNUS ), a leading provider of ...nt of venous disease, today announced its,financia..., 2008., Net revenues for the third quarter of 20...7.5 million for the third quarter of 2007. Net,rev...
Other Biology Technology:Sangamo BioSciences Reports Third Quarter 2008 Financial Results 2Sangamo BioSciences Reports Third Quarter 2008 Financial Results 3Sangamo BioSciences Reports Third Quarter 2008 Financial Results 4Sangamo BioSciences Reports Third Quarter 2008 Financial Results 5Sangamo BioSciences Reports Third Quarter 2008 Financial Results 6Sangamo BioSciences Reports Third Quarter 2008 Financial Results 7Aware, Inc. Announces Extension of Stock Repurchase Plan 2VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 2VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 3VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 4VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 5VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 6VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 7VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 8VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 9VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007 10
Amido Black 10B, CI 20470 from Research Organics, Inc.
Anti-Taste Receptor 2 (TR2) Polyclonal Antibody, Unconjugated from CHEMICON
Mouse Anti-Yersinia pestis Monoclonal Antibody, Unconjugated, Clone YPF19 from GeneTex
Anti-Human Ig Lambda-chain Monoclonal Antibody, Unconjugated, Clone ICO-16 from Cell Sciences
Biology Products: